<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Shao W</submitter><pubmed_abstract>Simultaneous photothermal therapy (PTT) and photodynamic therapy (PDT) is beneficial for enhanced cancer therapy due to the synergistic effect. Conventional materials developed for synergistic PTT/PDT are generally multicomponent agents that need complicated preparation procedures and be activated by multiple laser sources. The emerging monocomponent diketopyrrolopyrrole (DPP)-based conjugated small molecular agents enable dual PTT/PDT under a single laser irradiation, but suffer from low singlet oxygen quantum yield, which severely restricts the therapeutic efficacy. Herein, we report acceptor-oriented molecular design of a donor-acceptor-donor (D-A-D) conjugated small molecule (IID-ThTPA)-based phototheranostic agent, with isoindigo (IID) as selective acceptor and triphenylamine (TPA) as</pubmed_abstract><journal>Nano-micro letters</journal><pagination>147</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7770699</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular Design of Conjugated Small Molecule Nanoparticles for Synergistically Enhanced PTT/PDT.</pubmed_title><pmcid>PMC7770699</pmcid><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Wang N</pubmed_authors><pubmed_authors>Ling D</pubmed_authors><pubmed_authors>Shao W</pubmed_authors><pubmed_authors>Li F</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Ding Q</pubmed_authors><pubmed_authors>Yang C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular Design of Conjugated Small Molecule Nanoparticles for Synergistically Enhanced PTT/PDT.</name><description>Simultaneous photothermal therapy (PTT) and photodynamic therapy (PDT) is beneficial for enhanced cancer therapy due to the synergistic effect. Conventional materials developed for synergistic PTT/PDT are generally multicomponent agents that need complicated preparation procedures and be activated by multiple laser sources. The emerging monocomponent diketopyrrolopyrrole (DPP)-based conjugated small molecular agents enable dual PTT/PDT under a single laser irradiation, but suffer from low singlet oxygen quantum yield, which severely restricts the therapeutic efficacy. Herein, we report acceptor-oriented molecular design of a donor-acceptor-donor (D-A-D) conjugated small molecule (IID-ThTPA)-based phototheranostic agent, with isoindigo (IID) as selective acceptor and triphenylamine (TPA) as</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2026-05-07T17:12:23.779Z</modification><creation>2026-04-07T23:04:28.388Z</creation></dates><accession>S-EPMC7770699</accession><cross_references><pubmed>34138129</pubmed><doi>10.1007/s40820-020-00474-6</doi></cross_references></HashMap>